In‐depth analysis of the clinical significance of USP53 expression and tumor stages, ccRCC samples were divided into I‐II, III, and IV stages, the results showed that as tumor grade increases, USP53 expression decreases (Figure 1C). The gene discussed is USP53; the disease is nonpapillary renal cell carcinoma.